| abstract |
The present invention relates to N-alkyl-2- (1- (5-substituted-2- (3-oxo-3- (trifluoromethylsulfonamido) propyl) benzyl) pyrrolidin-2-yl) oxazole-4-carboxamide. A compound is provided wherein the five substituents are selected from the group consisting of halo and alkyloxy groups. The compound may be represented by the following formula: [Chemical 1] Wherein R 1 is selected from the group consisting of CO 2 R 7 and CON (R 7 ) SO 2 R 7 , wherein R 1 , R 2 , R 3 , R 4 , and R 7 are defined in the specification. That's right. The compounds, DP 1, FP, EP 1 , EP 3, TP and / or EP 4 receptor may be administered to treat a disease or condition mediated. [Selection figure] None |